The use of hypomethylating agents in hematologic malignancies: treatment preferences and results
{{output}}
Aim: The objective of this article was to compare the efficiency of azacitidine (AZA) and decitabine (DAC) in patients with myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) who are not suitable for high-dose chemot... ...
